Biosimilar Growth Hormones Global Market Report 2023
Report Highlights
Including: 1) By Route Of Administration: Intravenous; Subcutaneous; Intramuscular; Oral
2) By Application: Growth Hormone Deficiency; Turner Syndrome; Idiopathic Short Stature; Prader Willi Syndrome
3) By Distribution Channel: Hospital And Retail Pharmacy; Online Pharmacy/ePharmacy; Speciality Clinics
Covering: Biopartners And LG Chem; Amega Biotech; Eli Lilly and Company; Genetech Inc.; Novartis AG
Biosimilar Growth Hormones Global Market Report 2023 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on biosimilar growth hormones market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
- Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
- Assess the Russia – Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
- Measure the impact of high global inflation on market growth.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description:
Where is the largest and fastest growing market for biosimilar growth hormones ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The biosimilar growth hormones market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
Report Synopsis
Report Metrics | Details |
Base year considered | 2022 |
Forecast period considered | 2022-2032 |
Units considered | $ Billion |
Segments covered | By Route Of Administration, By Application, By Distribution Channel |
Industry covered | Pharmaceuticals |
Regions covered | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
Countries covered | Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA |
Companies studied |
|
Scope
Markets Covered:
- By Route Of Administration: Intravenous; Subcutaneous; Intramuscular; Oral
- By Application: Growth Hormone Deficiency; Turner Syndrome; Idiopathic Short Stature; Prader Willi Syndrome; Other Applications
- By Distribution Channel: Hospital And Retail Pharmacy; Online Pharmacy/ePharmacy; Speciality Clinics
Companies Mentioned: Biopartners And LG Chem; Amega Biotech; Eli Lilly and Company; Genetech Inc.; Novartis AG
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
- Table 1 : Global Historic Market Growth, 2017-2022, $ Billion
- Table 2 : Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
- Table 3 : Global Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 4 : Global Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 5 : Global Biosimilar Growth Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 6 : Global Biosimilar Growth Hormones Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 7 : Global Biosimilar Growth Hormones Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 8 : Asia-Pacific, Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 9 : Asia-Pacific, Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 10 : China, Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 11 : China, Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 12 : India, Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 13 : India, Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 14 : Japan, Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 15 : Japan, Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 16 : Australia, Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 17 : Australia, Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 18 : Indonesia, Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 19 : Indonesia, Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 20 : South Korea, Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 21 : South Korea, Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 22 : Western Europe, Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 23 : Western Europe, Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 24 : UK, Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 25 : UK, Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 26 : Germany, Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 27 : Germany, Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 28 : France, Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 29 : France, Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 30 : Eastern Europe, Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 31 : Eastern Europe, Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 32 : Russia, Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 33 : Russia, Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 34 : North America, Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 35 : North America, Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 36 : USA, Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 37 : USA, Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 38 : South America, Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 39 : South America, Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 40 : Brazil, Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 41 : Brazil, Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 42 : Middle East, Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 43 : Middle East, Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 44 : Africa, Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 45 : Africa, Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 46 : Biopartners And LG Chem Financial Performance
- Table 47 : Amega Biotech Financial Performance
- Table 48 : Eli Lilly and Company Financial Performance
- Table 49 : Genetech Inc. Financial Performance
- Table 50 : Novartis AG Financial Performance
- Figure 1 : Global Historic Market Growth, 2017-2022, $ Billion
- Figure 2 : Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
- Figure 3 : Global Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 4 : Global Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 5 : Global Biosimilar Growth Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 6 : Global Biosimilar Growth Hormones Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 7 : Global Biosimilar Growth Hormones Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 8 : Asia-Pacific, Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 9 : Asia-Pacific, Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 10 : China, Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 11 : China, Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 12 : India, Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 13 : India, Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 14 : Japan, Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 15 : Japan, Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 16 : Australia, Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 17 : Australia, Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 18 : Indonesia, Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 19 : Indonesia, Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 20 : South Korea, Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 21 : South Korea, Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 22 : Western Europe, Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 23 : Western Europe, Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 24 : UK, Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 25 : UK, Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 26 : Germany, Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 27 : Germany, Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 28 : France, Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 29 : France, Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 30 : Eastern Europe, Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 31 : Eastern Europe, Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 32 : Russia, Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 33 : Russia, Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 34 : North America, Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 35 : North America, Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 36 : USA, Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 37 : USA, Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 38 : South America, Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 39 : South America, Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 40 : Brazil, Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 41 : Brazil, Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 42 : Middle East, Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 43 : Middle East, Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 44 : Africa, Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 45 : Africa, Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 46 : Biopartners And LG Chem Financial Performance
- Figure 47 : Amega Biotech Financial Performance
- Figure 48 : Eli Lilly and Company Financial Performance
- Figure 49 : Genetech Inc. Financial Performance
- Figure 50 : Novartis AG Financial Performance
The Business Research Company is a market research and intelligence company which excels in company, market and consumer research. It has over 50 research professionals at its offices in India, the UK and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.
Similar Reports from TBRC (Publisher)
Biosimilar Growth Hormones Global Market Report 2022
Including: 1) By Route Of Administration: Intravenous; Subcutaneous; Intramuscular; Oral
2) By Application: Growth Hormone Deficiency; Turner Syndrome; Idiopathic Short Stature; Prader Willi Syndrome; Others
3) By Distribution Channel: Hospital And Retail Pharmacy; Online Pharmacy/ePharmacy; Speciality Clinics
Covering: Biopartners And LG Chem; Amega Biotech; Eli Lilly and Company; Genetech inc.; Novartis AG; Zhongshan Hygene Biopharm Co. Ltd.
Biosimilar ...
Biosimilar Growth Hormones Global Market Report 2021: COVID-19 Growth And Change To 2030
Including: 1) By Route Of Administration: Intravenous; Subcutaneous; Intramuscular; Oral
2) By Application: Growth Hormone Deficiency; Turner Syndrome; Idiopathic Short Stature; Prader Willi Syndrome; Others
3) By Distribution Channel: Hospital And Retail Pharmacy; Online Pharmacy/ePharmacy; Speciality Clinics
Covering: Biopartners And LG Chem; Amega Biotech; Eli Lilly and Company; Genetech Inc.; Novartis AG
Biosimilar Growth Hormones Global Market Report ...
Biosimilar Growth Hormones Global Market Report 2020-30: Covid 19 Growth and Change
Including: 1) By Route Of Administration: Intravenous; Subcutaneous; Intramuscular; Oral
2) By Application: Growth Hormone Deficiency; Turner Syndrome; Idiopathic Short Stature; Prader Willi Syndrome; Others
3) By Distribution Channel: Hospital And Retail Pharmacy; Online Pharmacy/ePharmacy; Speciality Clinics
Covering: Biopartners And LG Chem; Amega Biotech; Eli Lilly and Company; Genetech Inc.; Novartis AG
Biosimilar Growth Hormones Global Market Report 2020-30: COVID ...